Taegwon Oh

1.7k total citations
15 papers, 449 citations indexed

About

Taegwon Oh is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Taegwon Oh has authored 15 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Organic Chemistry. Recurrent topics in Taegwon Oh's work include Tuberculosis Research and Epidemiology (5 papers), Synthesis and biological activity (4 papers) and Cancer therapeutics and mechanisms (3 papers). Taegwon Oh is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Synthesis and biological activity (4 papers) and Cancer therapeutics and mechanisms (3 papers). Taegwon Oh collaborates with scholars based in South Korea, United States and Yemen. Taegwon Oh's co-authors include Pilho Kim, Sang-Nae Cho, Sang-Nae Cho, Won‐Jung Koh, Kyeongman Jeon, Keehoon Lee, Sung Jae Shin, Seonwoo Kim, Ae‐Ran Kwon and Takushi Kaneko and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Bacteriology and Clinical Orthopaedics and Related Research.

In The Last Decade

Taegwon Oh

15 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taegwon Oh South Korea 9 208 175 173 123 97 15 449
Maria Cristina da Silva Lourenço Brazil 9 86 0.4× 144 0.8× 133 0.8× 59 0.5× 50 0.5× 26 306
Françoise Roquet‐Banères France 14 145 0.7× 343 2.0× 367 2.1× 151 1.2× 97 1.0× 22 574
Uday S. Ganapathy United States 11 102 0.5× 268 1.5× 264 1.5× 132 1.1× 66 0.7× 18 393
Jozef Stec United States 10 213 1.0× 261 1.5× 203 1.2× 203 1.7× 19 0.2× 18 478
Shajila Siricilla United States 11 119 0.6× 131 0.7× 64 0.4× 229 1.9× 23 0.2× 17 382
Dereje A. Negatu United States 10 60 0.3× 175 1.0× 139 0.8× 153 1.2× 25 0.3× 17 322
Sang-Nae Cho South Korea 9 86 0.4× 178 1.0× 123 0.7× 202 1.6× 11 0.1× 14 439
Manju Yasoda Krishnan India 13 58 0.3× 250 1.4× 212 1.2× 197 1.6× 18 0.2× 25 434
Norio Doi Japan 10 65 0.3× 256 1.5× 199 1.2× 157 1.3× 15 0.2× 20 389
Tamara Hess United States 7 122 0.6× 364 2.1× 273 1.6× 273 2.2× 21 0.2× 7 567

Countries citing papers authored by Taegwon Oh

Since Specialization
Citations

This map shows the geographic impact of Taegwon Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taegwon Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taegwon Oh more than expected).

Fields of papers citing papers by Taegwon Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taegwon Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taegwon Oh. The network helps show where Taegwon Oh may publish in the future.

Co-authorship network of co-authors of Taegwon Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Taegwon Oh. A scholar is included among the top collaborators of Taegwon Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taegwon Oh. Taegwon Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bhattarai, Deepak, Muhammad Muddassar, Jae Young Jang, et al.. (2015). Virtual Screening and Synthesis of Novel Antitubercular Agents Through Interaction-Based Pharmacophore and Molecular Docking Studies. Current Computer - Aided Drug Design. 10(4). 383–392. 2 indexed citations
2.
Oh, Taegwon, Faisal Hayat, Euna Yoo, et al.. (2015). Antitubercular Activities of the Novel Synthesized 1,2,4‐Triazole Derivatives. Bulletin of the Korean Chemical Society. 36(1). 43–51. 7 indexed citations
3.
Bhattarai, Deepak, Seon Hee Seo, Ghilsoo Nam, et al.. (2014). Synthesis and <i>in Vitro</i> Evaluation of the Antitubercular and Antibacterial Activity of Novel Oxazolidinones Bearing Octahydrocyclopenta[<i>c</i>]pyrrol-2-yl Moieties. Chemical and Pharmaceutical Bulletin. 62(12). 1214–1224. 8 indexed citations
4.
Han, Chang Dong, Taegwon Oh, Sang-Nae Cho, Jae‐Ho Yang, & Kwan Kyu Park. (2013). Isoniazid Could Be Used for Antibiotic-loaded Bone Cement for Musculoskeletal Tuberculosis: An In Vitro Study. Clinical Orthopaedics and Related Research. 471(7). 2400–2406. 17 indexed citations
5.
Oh, Taegwon, Takushi Kaneko, Anna M. Upton, et al.. (2013). Design, Synthesis, and Structure–Activity Relationship Studies of Tryptanthrins As Antitubercular Agents. Journal of Natural Products. 76(3). 354–367. 99 indexed citations
6.
Choi, Go Eun, Sung Jae Shin, Taegwon Oh, et al.. (2012). Macrolide Treatment for Mycobacterium abscessus and Mycobacterium massiliense Infection and Inducible Resistance. American Journal of Respiratory and Critical Care Medicine. 186(9). 917–925. 150 indexed citations
7.
Bhattarai, Deepak, Sun H. Lee, Ghilsoo Nam, et al.. (2012). Synthesis and In Vitro Antibacterial Activity of Novel 3‐Azabicyclo[3.3.0]octanyl Oxazolidinones. Chemical Biology & Drug Design. 80(3). 388–397. 11 indexed citations
8.
Kim, Suhyun, Sang-Nae Cho, Taegwon Oh, & Pilho Kim. (2012). Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents. Bioorganic & Medicinal Chemistry Letters. 22(22). 6844–6847. 42 indexed citations
9.
Lee, Sang‐Ho, Suhyun Kim, Yong Sup Lee, et al.. (2011). Synthesis and antitubercular activity of monocyclic nitroimidazoles: Insights from econazole. Bioorganic & Medicinal Chemistry Letters. 21(5). 1515–1518. 36 indexed citations
10.
Kim, Su‐Young, Hosung Sohn, Go Eun Choi, et al.. (2011). Conversion of Mycobacterium smegmatis to a pathogenic phenotype via passage of epithelial cells during macrophage infection. Medical Microbiology and Immunology. 200(3). 177–191. 5 indexed citations
11.
Muddassar, Muhammad, Yong Seo Cho, Gyochang Keum, et al.. (2010). Identification of novel antitubercular compounds through hybrid virtual screening approach. Bioorganic & Medicinal Chemistry. 18(18). 6914–6921. 25 indexed citations
12.
Kwon, Ae‐Ran, Taegwon Oh, Dong‐Hyun Kim, & Eung‐Chil Choi. (1999). Molecular Cloning of the Arylsulfate Sulfotransferase Gene and Characterization of Its Product from Enterobacter amnigenus AR-37. Protein Expression and Purification. 17(3). 366–372. 20 indexed citations
13.
Oh, Taegwon, et al.. (1998). Resistance to macrolide-lincosamide-streptogramin B antibiotics is induced by 16 memberedring macrolide antibiotics inEnterococcus faecalis 373. Archives of Pharmacal Research. 21(1). 76–78. 4 indexed citations
14.
Oh, Taegwon, Ae‐Ran Kwon, & Eung‐Chil Choi. (1998). Induction of ermAMR from a Clinical Strain of Enterococcus faecalis by 16-Membered-Ring Macrolide Antibiotics. Journal of Bacteriology. 180(21). 5788–5791. 20 indexed citations
15.
Baek, Moon‐Chang, et al.. (1997). Overexpression of Arylsulfate Sulfotransferase as Fusion Protein with GlutathioneS-Transferase. Protein Expression and Purification. 11(3). 257–262. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026